Esphera Synbio

Developer of cancer and immunoregulatory treatments using synthetic biology

placeOttawa, Ontario, Canada calendar_todayFounded 2022 language espherasynbio.ca

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 4 times.

YearFilings
20251

Social engagement

Social engagement: 682 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon